Dennis O'Malley

Herbolea is a biotech company envisioning the use of innovative, green technologies to obtain safe, high-quality and low-cost natural products. Herbolea’s patented Bio-refining Platform generates unique products from highly therapeutic potential botanicals in a safe, environmentally friendly, and cost-competitive way. The company has signed licensing agreements with pharmaceutical companies in US, Canada, Colombia, Germany, Portugal, Italy, Zimbabwe, Thailand and Morocco. The company has assembled a team of highly seasoned executives with a proven track record in building successful companies.

Herbolea is a biotech company envisioning the use of innovative, green technologies to obtain safe, high-quality and low-cost natural products. Herbolea’s patented Bio-refining Platform generates unique products from highly therapeutic potential botanicals in a safe, environmentally friendly, and cost-competitive way. The company has signed licensing agreements with pharmaceutical companies in US, Canada, Colombia, Germany, Portugal, Italy, Zimbabwe, Thailand and Morocco. The company has assembled a team of highly seasoned executives with a proven track record in building successful companies.

Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.

Advisory firm to innovative companies in cannabis and technology.

Today’s consumers are expected to navigate an increasingly complicated digital world. Pain points throughout the customer journey cause frustration and hesitation, ultimately leading to abandonment. goMoxie proactively guides users throughout the online journey, creating self-sufficient and self-assured customers, which leads to dramatically improved conversion rates, an increase in up-sells, and faster company growth. Create certainty, empower customers, and get results with goMoxie.